Alector (ALEC) News Today $1.86 +0.08 (+4.49%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Hold" from BrokeragesShares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have been assigned an average rating of "Hold" from the seven brokerages that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and three haveDecember 21 at 4:46 AM | marketbeat.comAlector (NASDAQ:ALEC) Cut to "Neutral" at MizuhoDecember 20 at 2:49 AM | americanbankingnews.comAlector (NASDAQ:ALEC) Stock Rating Lowered by Stifel NicolausDecember 18 at 1:55 AM | americanbankingnews.comAlector downgraded to Neutral from Outperform at MizuhoDecember 17, 2024 | markets.businessinsider.comAlector (NASDAQ:ALEC) Stock Rating Lowered by MizuhoMizuho cut shares of Alector from an "outperform" rating to a "neutral" rating and dropped their target price for the stock from $9.00 to $2.50 in a research report on Tuesday.December 17, 2024 | marketbeat.comStifel Downgrades Alector (ALEC)December 17, 2024 | msn.comMizuho Securities downgrades Alector (ALEC) to a HoldDecember 17, 2024 | markets.businessinsider.comAlector (NASDAQ:ALEC) Rating Lowered to "Hold" at Stifel NicolausStifel Nicolaus cut Alector from a "buy" rating to a "hold" rating and set a $4.00 target price on the stock. in a report on Monday.December 16, 2024 | marketbeat.comVerition Fund Management LLC Sells 473,794 Shares of Alector, Inc. (NASDAQ:ALEC)Verition Fund Management LLC lowered its stake in Alector, Inc. (NASDAQ:ALEC - Free Report) by 88.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 64,369 shares of the company's stock after selling 473,794 shares during the quarter. Verition Fund ManagemenDecember 15, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Sees Significant Increase in Short InterestAlector, Inc. (NASDAQ:ALEC - Get Free Report) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 5,390,000 shares, an increase of 34.1% from the November 15th total of 4,020,000 shares. Based on an average daily volume of 1,010,000 shares, the short-interest ratio is presently 5.3 days. Approximately 7.1% of the company's stock are sold short.December 13, 2024 | marketbeat.comPoint72 Asset Management L.P. Decreases Stake in Alector, Inc. (NASDAQ:ALEC)Point72 Asset Management L.P. lowered its stake in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 86.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,538 shares of the company's stock afteDecember 13, 2024 | marketbeat.comBank of America Downgrades Alector (NASDAQ:ALEC) to UnderperformBank of America downgraded Alector from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $9.00 to $1.00 in a research note on Wednesday.December 4, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) CFO Sells $41,552.28 in StockDecember 4, 2024 | insidertrades.comBraidwell LP Cuts Stock Position in Alector, Inc. (NASDAQ:ALEC)Braidwell LP decreased its stake in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 9.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,158,245 shares of the company's stock after selling 222,459 shares duringNovember 29, 2024 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Alector (NASDAQ:ALEC) Stock PriceHC Wainwright cut their target price on shares of Alector from $35.00 to $7.00 and set a "buy" rating for the company in a research report on Friday.November 29, 2024 | marketbeat.comWhat is HC Wainwright's Forecast for Alector Q1 Earnings?Alector, Inc. (NASDAQ:ALEC - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Alector in a research note issued to investors on Tuesday, November 26th. HC Wainwright analyst A. Fein anticipates that the company will pNovember 28, 2024 | marketbeat.comAlector: Bleak Prospects After Alzheimer's FailureNovember 28, 2024 | seekingalpha.comMorgan Stanley Downgrades Alector (ALEC)November 27, 2024 | msn.comAlector’s Strategic Pipeline and Promising PGRN Program Justify Buy Rating Despite AL002 SetbackNovember 27, 2024 | markets.businessinsider.comAlector turns to layoffs as Alzheimer’s drug failsNovember 27, 2024 | finance.yahoo.comBuy Rating Maintained for Alector Despite AL002 Setback, Focus on Promising AL001 and Strong FinancialsNovember 26, 2024 | markets.businessinsider.comAlector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business UpdateNovember 26, 2024 | finance.yahoo.comAlector stock drops after Alzheimer’s drug fails in Phase II trialNovember 26, 2024 | finance.yahoo.comAlector (NASDAQ:ALEC) Rating Lowered to "Underweight" at Morgan StanleyMorgan Stanley cut shares of Alector from an "equal weight" rating to an "underweight" rating and lowered their target price for the stock from $10.00 to $3.00 in a research note on Tuesday.November 26, 2024 | marketbeat.comAlector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer's Disease and Provides Business UpdateNovember 25, 2024 | globenewswire.comAlector’s Strategic Advances in Immuno-NeurologyNovember 22, 2024 | markets.businessinsider.comAlector Secures Funding to Advance Clinical TrialsNovember 15, 2024 | markets.businessinsider.comAlector Secures Flexible Credit Facility for Up to $50 Million From Hercules CapitalNovember 14, 2024 | globenewswire.comAlector, Inc. (NASDAQ:ALEC) Shares Sold by Baillie Gifford & Co.Baillie Gifford & Co. cut its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 69.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 78,835 shares of the company's stock after selling 181,November 14, 2024 | marketbeat.comFY2024 Earnings Forecast for Alector Issued By HC WainwrightAlector, Inc. (NASDAQ:ALEC - Free Report) - Equities research analysts at HC Wainwright lifted their FY2024 earnings per share (EPS) estimates for Alector in a report released on Thursday, November 7th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($1.79) per share for tNovember 11, 2024 | marketbeat.comWilliam Blair Has Strong Outlook for Alector FY2024 EarningsAlector, Inc. (NASDAQ:ALEC - Free Report) - Investment analysts at William Blair increased their FY2024 earnings estimates for shares of Alector in a research note issued to investors on Wednesday, November 6th. William Blair analyst M. Minter now anticipates that the company will post earnings pNovember 11, 2024 | marketbeat.comAlector (NASDAQ:ALEC) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPSAlector (NASDAQ:ALEC - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.43) earnings per share for the quarter, topping analysts' consensus estimates of ($0.53) by $0.10. The firm had revenue of $15.34 million during the quarter, compared to analysts' expectations of $16.33 million. Alector had a negative net margin of 290.66% and a negative return on equity of 102.63%.November 9, 2024 | marketbeat.comStifel Nicolaus Sticks to Its Buy Rating for Alector (ALEC)November 9, 2024 | markets.businessinsider.comPromising Developments in Alector’s Alzheimer’s Treatments Drive Buy RatingNovember 7, 2024 | markets.businessinsider.comAlector’s Promising Phase 2 Study and Strong Financial Outlook Justify Buy RatingNovember 7, 2024 | markets.businessinsider.comAlector (NASDAQ:ALEC) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $35.00 price target on shares of Alector in a research note on Thursday.November 7, 2024 | marketbeat.comAlector Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 6, 2024 | globenewswire.comAlector (NASDAQ:ALEC) Stock Price Up 7% - Still a Buy?Alector (NASDAQ:ALEC) Trading 7% Higher - Should You Buy?November 4, 2024 | marketbeat.comIs Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?October 30, 2024 | finance.yahoo.comCautious Optimism for Alector’s AL002 Amid Promising Alzheimer’s Data and Investor CautionOctober 25, 2024 | markets.businessinsider.comAlector (ALEC) Receives a Buy from BarclaysOctober 19, 2024 | markets.businessinsider.comAlector, Inc. (NASDAQ:ALEC) Short Interest Up 19.9% in SeptemberAlector, Inc. (NASDAQ:ALEC - Get Free Report) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totalling 4,150,000 shares, a growth of 19.9% from the September 15th total of 3,460,000 shares. Based on an average daily volume of 553,000 shares, the short-interest ratio is currently 7.5 days. Currently, 5.5% of the shares of the stock are short sold.October 14, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Holdings Trimmed by Marshall Wace LLPMarshall Wace LLP lowered its position in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 70.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 52,609 shares of the company's stock after selling 124,October 13, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 169,888 Shares of Alector, Inc. (NASDAQ:ALEC)Dimensional Fund Advisors LP trimmed its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 20.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 676,076 shares of the company's stock after sellOctober 11, 2024 | marketbeat.comCalluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the BoardOctober 9, 2024 | finance.yahoo.comAlector’s AL002 Holds Potential Amidst Uncertainties: A Hold Rating AnalysisOctober 1, 2024 | markets.businessinsider.comOne in Three Former NFL Players Believe They Have CTESeptember 24, 2024 | msn.comAlector (NASDAQ:ALEC) Shares Down 5.6% Alector (NASDAQ:ALEC) Stock Price Down 5.6%September 23, 2024 | marketbeat.comAlector (NASDAQ:ALEC) investors are sitting on a loss of 77% if they invested three years agoSeptember 19, 2024 | finance.yahoo.comCantor Fitzgerald Reaffirms Overweight Rating for Alector (NASDAQ:ALEC)Cantor Fitzgerald reissued an "overweight" rating on shares of Alector in a research note on Tuesday.September 17, 2024 | marketbeat.com Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover ALEC Media Mentions By Week ALEC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALEC News Sentiment▼-0.370.59▲Average Medical News Sentiment ALEC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALEC Articles This Week▼113▲ALEC Articles Average Week Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Immunome News Kura Oncology News Keros Therapeutics News Tyra Biosciences News Cronos Group News Erasca News Evolus News Dianthus Therapeutics News Rapport Therapeutics News Autolus Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALEC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alector, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alector With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
